Prosecution Insights
Last updated: April 19, 2026

Examiner: FRUMKIN, JESSE P

Tech Center 2600 • Art Units: 1600 1631 1671 1685 2156 2687

This examiner grants 70% of resolved cases

Performance Statistics

70.1%
Allow Rate
+8.1% vs TC avg
278
Total Applications
+47.6%
Interview Lift
1396
Avg Prosecution Days
Based on 251 resolved cases, 2023–2026

Rejection Statute Breakdown

16.6%
§101 Eligibility
27.9%
§102 Novelty
27.3%
§103 Obviousness
13.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17418174 DISEASE PREDICTING SYSTEM Non-Final OA KYOCERA Corporation
16552375 Segmentation Of Video According To Narrative Theme Non-Final OA Comcast Cable Communications, LLC
17599325 GRID OF RESPONSES INDICATING DRUG SENSITIVITY Non-Final OA The Johns Hopkins University
17987387 Database Security Final Rejection Ab Initio Technology LLC
18602428 GENE MUTATIONS ASSOCIATED WITH TANDEM DUPLICATOR PHENOTYPE Non-Final OA The Jackson Laboratory
18219325 SYSTEMS AND METHODS FOR ARTIFICIAL INTELLIGENCE-BASED PREDICTION OF AMINO ACID SEQUENCES AT A BINDING INTERFACE Non-Final OA Pythia Labs, Inc.
18645588 COMBINATION THERAPY WITH DIGITAL THERAPEUTICS FOR IMPROVED NEURO-CONNECTIVITY Final Rejection REMEPY HEALTH LTD
18605798 Models for Targeted Sequencing Non-Final OA GRAIL, LLC
17789402 METHOD AND SYSTEM FOR ESTIMATING RENAL FUNCTION Non-Final OA National Institutes of Biomedical Innovation, Health and Nutrition
17273821 Method for Engineering Synthetic Cis-Regulatory DNA Non-Final OA Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft
17339583 DISCOVERING GENOMES TO USE IN MACHINE LEARNING TECHNIQUES Non-Final OA Analytics For Life Inc.
17769516 Artificial Intelligence Model for Predicting Indications for Test Substances in Humans Non-Final OA KARYDO THERAPEUTIX, INC.
17856782 SYSTEMS AND METHODS FOR DYNAMICALLY PROVIDING DYNAMIC NUTRITIONAL GUIDANCE Non-Final OA Inspiring Healthcare, LLC
17769954 Method for Predicting a Suitable Therapy Non-Final OA Kyan Therapeutics

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month